About Contact Us Careers

HLA Typing for Transplant Market Share

Request Free Sample Copy

Report ID: 2629
Published Date: Oct 15, 2024
Report Format: PDF, PPT

Buy Now

HLA Typing for Transplant Market Share

Based on geographically, the HLA typing for transplant market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region.

North America industry is poised to account for largest revenue share by 2036, on account of the presence of a highly developed healthcare system, large volume of organ transplantation procedures performed in the region, high adoption of innovative transplant diagnostic technologies (includes HLA typing) among medical professionals and technological advancements in the field of transplant diagnostics.

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:

HLA Typing for Transplant Market Size & Share, Growth Trends 2036

Author Credits: Radhika Pawar

Report ID: 2629
Published Date: Oct 15, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of HLA typing for transplant is estimated at USD 843.51 million.

HLA Typing for Transplant Market size was over USD 803.65 million in 2023 and is anticipated to cross USD 1.75 billion by 2036, witnessing more than 6.2% CAGR during the forecast period i.e., between 2024-2036.

The major players in the market are Immucor, Inc., Illumina, Inc., CareDx, Inc., QIAGEN N.V., Bio-Rad Laboratories, Inc., F. Hoffman-La Roche Ltd., Biofortuna Limited, Takara Bio Inc., Omixon Inc., and others.

Inquiry Before Buying Request Free Sample